22 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
assurance activities at global level in relation to key privacy risks. The Company conducted the following actions for cybersecurity: Since … the Company recognized the critical role that cybersecurity plays in ensuring trusted digital interactions with the Company’s stakeholders, the Company
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
various assurance activities at global level in relation to key privacy risks. The Company conducted the following actions for cybersecurity: Since … the Company recognized the critical role that cybersecurity plays in ensuring trusted digital interactions with the Company’s stakeholders, the Company
6-K
TAK
Takeda Pharmaceutical Co
11 Jul 22
Current report (foreign)
6:05am
, for example, manufacturing sites and IT cybersecurity.
For crisis management, the Company has developed a crisis management system structured around
6-K
EX-99.1
2vys4
31 May 22
Current report (foreign)
12:00am
6-K
nsihuab k8got
1 Nov 21
Current report (foreign)
6:04am
6-K
i2bnku1g
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
fmd0k75wcdqp6doytary
28 May 21
Current report (foreign)
6:03am
6-K
EX-99.1
qrp8xfl3ruc2 rg54
17 Dec 20
Current report (foreign)
6:01am
6-K
om24txyz0 ojouy0jrvh
27 May 20
Current report (foreign)
6:05am
6-K
EX-99.1
ly7h0b156i3s
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
xch5ezfu
14 Nov 19
Prospectus supplement
6:10am
F-4/A
z9iavtjbginz6f ea59
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
1jj0qadb 24u6qsu3sb
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
d3amtms3g8sc56158zk
27 Jun 19
Annual report (foreign)
6:41am
6-K
68xqmr3xnoy0onn
30 May 19
Current report (foreign)
10:26am
20FR12B/A
wyfpooolkff6kc
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am